GNS
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
27.06M
41 days until earnings call
Intraday BUY SELL Signals
XXI
Price
$5.63
Change
-$0.27 (-4.58%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
2.04B
22 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GNS vs XXI

GNS vs XXI Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GNS vs. XXI commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNS is a Hold and XXI is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for GNS with price predictions
Oct 22, 2026

GNS sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for GNS moved above the 200-day moving average on September 22, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 50 of 56 cases where GNS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.

Following a +7.47% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNS advanced for three days, in 139 of 165 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

GNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GNS as a result. In 64 of 69 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

GNS moved below its 50-day moving average on October 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for GNS crossed bearishly below the 50-day moving average on October 06, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for GNS entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.274) is normal, around the industry mean (1.349). P/E Ratio (-0.522) is within average values for comparable stocks, (9.780). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.327). Dividend Yield (2.837) settles around the average of (4.828) among similar stocks. P/S Ratio (1.839) is also within normal values, averaging (27.566).

The Tickeron PE Growth Rating for this company is 23 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 37 (best 1 - 100 worst), indicating steady price growth. GNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

A.I.Advisor
a Summary for XXI with price predictions
Oct 22, 2026

XXI in -9.54% downward trend, declining for three consecutive days on October 19, 2026

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where XXI declined for three days, in 99 of 117 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on XXI as a result. In 19 of 30 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for XXI turned negative on October 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 21 similar instances when the indicator turned negative. In 13 of the 21 cases the stock turned lower in the days that followed. This puts the odds of success at 62%.

XXI moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for XXI crossed bearishly below the 50-day moving average on October 21, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 3 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 60%.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +7.09% 3-day Advance, the price is estimated to grow further. Considering data from situations where XXI advanced for three days, in 55 of 83 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

XXI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 40 of 70 cases where XXI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 30 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.937) is normal, around the industry mean (1.349). P/E Ratio (0.000) is within average values for comparable stocks, (9.780). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.327). Dividend Yield (0.000) settles around the average of (4.828) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (27.566).

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. XXI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. XXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

TECHNICAL ANALYSIS
Technical Analysis
GNSXXI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
58%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
63%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
74%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
66%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
57%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (GNS: $0.13 vs. XXI: $5.61)
Brand notoriety: GNS and XXI are both not notable
Both companies represent the Other Consumer Specialties industry
Current volume relative to the 65-day Moving Average: GNS: 25% vs. XXI: 88%
Market capitalization -- GNS: $25.82M vs. XXI: $1.94B
GNS [@Other Consumer Specialties] is valued at $25.82M. XXI’s [@Other Consumer Specialties] market capitalization is $1.94B. The market cap for tickers in the [@Other Consumer Specialties] industry ranges from $90 to $15B. The average market capitalization across the [@Other Consumer Specialties] industry is $1.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GNS’s FA Score shows that 2 FA rating(s) are green while XXI’s FA Score has 1 green FA rating(s).

  • GNS’s FA Score: 2 green, 3 red.
  • XXI’s FA Score: 1 green, 4 red.
According to our system of comparison, GNS is a better buy in the long-term than XXI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GNS’s TA Score shows that 4 TA indicator(s) are bullish while XXI’s TA Score has 4 bullish TA indicator(s).

  • GNS’s TA Score: 4 bullish, 5 bearish.
  • XXI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both GNS and XXI are a bad buy in the short-term.

Price Growth

GNS (@Other Consumer Specialties) experienced а -2.04% price change this week, while XXI (@Other Consumer Specialties) price change was -7.73% for the same time period.

The average weekly price growth across all stocks in the @Other Consumer Specialties industry was -2.95%. For the same industry, the average monthly price growth was -2.99%, and the average quarterly price growth was -16.92%.

Reported Earning Dates

GNS is expected to report earnings on Dec 02, 2026.

XXI is expected to report earnings on Nov 13, 2026.

Industries' Descriptions

@Other Consumer Specialties (-2.95% weekly)

‘Other Consumer Specialties’ represents an industry that typically sells durable consumer products, but do not have a classification in another category. The products include jewelry, smoke detectors, watches, collectibles and safety products. MSA Safety (makes products which enhances the safety and health of workers and protect facility infrastructures), Matthews International (memorialization business), Fitbit (makes wireless-enabled wearable technology devices that gauge data such as the number of steps walked, heart rate, quality of sleep), and Fossil Group (makes watches and accessories) have some of the largest market caps in this group.

View a ticker or compare two or three
GNS
Daily Signal:
Gain/Loss:
XXI
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

GNS and

Correlation & Price change

A.I.dvisor tells us that GNS and XXI have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNS and XXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNS
1D Price
Change %
GNS100%
-4.61%
XXI - GNS
28%
Poorly correlated
-4.75%
BCO - GNS
26%
Poorly correlated
+2.29%
SUGP - GNS
25%
Poorly correlated
-2.70%
RTO - GNS
24%
Poorly correlated
+8.75%
GFAI - GNS
23%
Poorly correlated
-4.95%
More

XXI and

Correlation & Price change

A.I.dvisor tells us that XXI and GNS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XXI and GNS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XXI
1D Price
Change %
XXI100%
-4.75%
GNS - XXI
28%
Poorly correlated
-4.61%
LPBBU - XXI
24%
Poorly correlated
N/A
CHGG - XXI
24%
Poorly correlated
+0.12%
OACC - XXI
21%
Poorly correlated
-0.19%
GOTU - XXI
20%
Poorly correlated
-3.08%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TDTF23.100.14
+0.61%
Northern Trust iBoxx 5-Year Target Duration TIPS ETF (TDTF)
ENO19.520.10
+0.53%
Entergy New Orleans LLC
SMIZ40.72-0.65
-1.57%
Zacks Small/Mid Cap ETF (SMIZ)
IQM92.90-6.74
-6.77%
Franklin Intelligent Machines ETF (IQM)
ONDL3.36-0.30
-8.20%
Defiance Daily Target 2X Long ONDS ETF (ONDL)